The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-based guidelines

Chest

Volumn 126, Issue 3 SUPPL., 2004, Pages 172S-173S

  Hirsh, Jack ^a   Guyatt, Gordon ^b   Albers, Gregory W ^b   Schünemann, Holger J ^b  

^a HENDERSON RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ENOXAPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; DRUG COST; DRUG INDICATION; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEALTH ECONOMICS; HUMAN; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

EID: 4644359641     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.3_suppl.172S     Document Type: Conference Paper

References (5)

1. Schünemann HJ, Munger H, Brower S, et al. Methodology for guideline development for the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(suppl):174S-L78S
2. McKibbon A, Hunt D, Richardson SW, et al. Finding the evidence. In Guyatt G, Rennie D, eds. Users' guides to the medical literature: a manual for evidence-based clinical practice. Chicago, IL: American Medical Association Press, 2002; 16
3. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2004; 126(suppl):483S-512S
4. Guyatt G, Schünemann H, Cook D, et al. Grades of recommendation for antithrombotic agents. Chest 2001; 119:3S-7S
5. Clagett GP, Sobel M, Jackson MR, et al. Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2004; 126(suppl):609S-626S